Latest News about RespRx
Recent news which mentions RespRx
PAOG Expects To Realize Revenue This Year From New CBD Nutraceuticals
February 18, 2021
From OTC
PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation
February 16, 2021
From OTC
PAOG Targets $18 Billion Anxiety And Depression Treatment Market
February 11, 2021
From OTC
From OTC
PAOG Confirms CBD Nutraceutical Development And Distribution Partners
February 02, 2021
From OTC
PAOG Publishes 2021 Cannabis Biopharmaceutical Strategic Outlook
January 14, 2021
From OTC
PAOG Dividend Update Included In 2021 Cannabis Biopharmaceutical Strategic Update Tomorrow
January 13, 2021
From OTC
PAOG Confirms Cannabis Biopharmaceutical Strategic Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021
January 12, 2021
From OTC
PAOG Cannabis Pharmaceutical and Nutraceutical 2021 Strategy Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2020
January 11, 2021
From OTC
PAOG Confirms Q4 2020 Revenue From Cannabis Asset Acquisition
January 08, 2021
From OTC
PAOG Takes Major CBD Pharmaceutical Development Step Forward
January 05, 2021
From OTC
PAOG Expects To Report First Post Acquisition Revenue In Q4 2020
December 22, 2020
From OTC
PAOG Develops CBD Nutraceutical For $12.7 Billion Market From Patented Extract Process
December 18, 2020
From OTC
PAOG Announces Puerto Rico Consortium For Clinical Investigation Engagement To Advance CBD COPD Nutraceutical Care Solution
December 17, 2020
From OTC
PAOG CEO Discusses 2020 Progress And PURA Dividend On MoneyTV
November 25, 2020
From OTC
From OTC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.